NYSE:GRDNHealthcare
What Guardian Pharmacy Services (GRDN)'s Q1 Beat, Steady Guidance and New Equity Shelf Mean For Shareholders
In early May 2026, Guardian Pharmacy Services reported first-quarter 2026 results showing year-over-year growth in sales to US$336.6 million and net income to US$13.3 million, confirmed its full-year 2026 revenue guidance of US$1.40–US$1.42 billion, elected Randall Lewis as a Class II director, and filed a shelf registration for Class A common stock including an ESOP-related offering of 633,206 shares worth US$23.58 million.
This mix of earnings growth, unchanged outlook, board refresh, and...